Ultrastructural Characteristics of Glucocorticoid-induced Osteoporosis

Overview

Journal Osteoporos Int

Specialties Endocrinology
Orthopedics

Date 2009 Apr 3

PMID 19340501

Citations 6

Authors

B Bouvard

M Audran

E Legrand

D Chappard

Affiliations

Soon will be listed here.

Citing Articles

Nuclear receptors in osteoclasts.

Bae S, Zeng S, Park-Min K Curr Opin Pharmacol. 2020; 53:8-17.

PMID: 32569976 PMC: 7669703. DOI: 10.1016/j.coph.2020.03.002.

GLUCOCORTICOID-INDUCED BONE DISEASE: MECHANISMS AND IMPORTANCE IN PEDIATRIC PRACTICE.

Sarinho E, Melo V Rev Paul Pediatr. 2017; 35(2):207-215.

PMID: 28977339 PMC: 5496716. DOI: 10.1590/1984-0462;2017/;35;2;00007.

Necrostatin-1 treatment inhibits osteocyte necroptosis and trabecular deterioration in ovariectomized rats.

Cui H, Zhu Y, Yang Q, Zhao W, Zhang S, Zhou A Sci Rep. 2016; 6:33803.

PMID: 27703177 PMC: 5050438. DOI: 10.1038/srep33803.

Multiscale alterations in bone matrix quality increased fragility in steroid induced osteoporosis.

Karunaratne A, Xi L, Bentley L, Sykes D, Boyde A, Esapa C Bone. 2015; 84:15-24.

PMID: 26657825 PMC: 4764652. DOI: 10.1016/j.bone.2015.11.019.

Glucocorticoid-induced bone loss is associated with abnormal intravertebral areal bone mineral density distribution.

Manning L, Briggs A, Van Doornum S, Kale A, Kantor S, Wark J Int J Endocrinol. 2013; 2013:768579.

PMID: 23737778 PMC: 3662195. DOI: 10.1155/2013/768579.

References

Yao W, Cheng Z, Busse C, Pham A, Nakamura M, Lane N . Glucocorticoid excess in mice results in early activation of osteoclastogenesis and adipogenesis and prolonged suppression of osteogenesis: a longitudinal study of gene expression in bone tissue from glucocorticoid-treated mice. Arthritis Rheum. 2008; 58(6):1674-86. PMC: 3892702. DOI: 10.1002/art.23454. View

Canalis E . Effect of glucocorticoids on type I collagen synthesis, alkaline phosphatase activity, and deoxyribonucleic acid content in cultured rat calvariae. Endocrinology. 1983; 112(3):931-9. DOI: 10.1210/endo-112-3-931. View

Kim H, Zhao H, Kitaura H, Bhattacharyya S, Brewer J, Muglia L . Glucocorticoids suppress bone formation via the osteoclast. J Clin Invest. 2006; 116(8):2152-60. PMC: 1518793. DOI: 10.1172/JCI28084. View

Ohnaka K, Taniguchi H, Kawate H, Nawata H, Takayanagi R . Glucocorticoid enhances the expression of dickkopf-1 in human osteoblasts: novel mechanism of glucocorticoid-induced osteoporosis. Biochem Biophys Res Commun. 2004; 318(1):259-64. DOI: 10.1016/j.bbrc.2004.04.025. View

Ito S, Suzuki N, Kato S, Takahashi T, Takagi M . Glucocorticoids induce the differentiation of a mesenchymal progenitor cell line, ROB-C26 into adipocytes and osteoblasts, but fail to induce terminal osteoblast differentiation. Bone. 2006; 40(1):84-92. DOI: 10.1016/j.bone.2006.07.012. View

Eijken M, Koedam M, van Driel M, Buurman C, Pols H, van Leeuwen J . The essential role of glucocorticoids for proper human osteoblast differentiation and matrix mineralization. Mol Cell Endocrinol. 2006; 248(1-2):87-93. DOI: 10.1016/j.mce.2005.11.034. View

Atmani H, Audrain C, Mercier L, Chappard D, Basle M . Phenotypic effects of continuous or discontinuous treatment with dexamethasone and/or calcitriol on osteoblasts differentiated from rat bone marrow stromal cells. J Cell Biochem. 2002; 85(3):640-50. DOI: 10.1002/jcb.10165. View

Canalis E, Mazziotti G, Giustina A, Bilezikian J . Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos Int. 2007; 18(10):1319-28. DOI: 10.1007/s00198-007-0394-0. View

Giustina A, Mazziotti G, Canalis E . Growth hormone, insulin-like growth factors, and the skeleton. Endocr Rev. 2008; 29(5):535-59. PMC: 2726838. DOI: 10.1210/er.2007-0036. View

10.

Stahn C, Lowenberg M, Hommes D, Buttgereit F . Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists. Mol Cell Endocrinol. 2007; 275(1-2):71-8. DOI: 10.1016/j.mce.2007.05.019. View

11.

van Staa T, Leufkens H, Cooper C . The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int. 2002; 13(10):777-87. DOI: 10.1007/s001980200108. View

12.

Vestergaard P, Rejnmark L, Mosekilde L . Fracture risk associated with different types of oral corticosteroids and effect of termination of corticosteroids on the risk of fractures. Calcif Tissue Int. 2008; 82(4):249-57. DOI: 10.1007/s00223-008-9124-7. View

13.

Dalle Carbonare L, Bertoldo F, Valenti M, Zenari S, Zanatta M, Sella S . Histomorphometric analysis of glucocorticoid-induced osteoporosis. Micron. 2005; 36(7-8):645-52. DOI: 10.1016/j.micron.2005.07.009. View

14.

OBrien C, Jia D, Plotkin L, Bellido T, Powers C, Stewart S . Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength. Endocrinology. 2003; 145(4):1835-41. DOI: 10.1210/en.2003-0990. View

15.

Jia D, OBrien C, Stewart S, Manolagas S, Weinstein R . Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density. Endocrinology. 2006; 147(12):5592-9. PMC: 1819400. DOI: 10.1210/en.2006-0459. View

16.

Chappard D, Josselin N, Rouge-Maillart C, Legrand E, Basle M, Audran M . Bone microarchitecture in males with corticosteroid-induced osteoporosis. Osteoporos Int. 2006; 18(4):487-94. DOI: 10.1007/s00198-006-0278-8. View

17.

Weinstein R, Jilka R, Parfitt A, Manolagas S . Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest. 1998; 102(2):274-82. PMC: 508885. DOI: 10.1172/JCI2799. View

18.

Hong D, Chen H, Ge R, Li J . The biological roles of extracellular and intracytoplasmic glucocorticoids in skeletal cells. J Steroid Biochem Mol Biol. 2008; 111(3-5):164-70. DOI: 10.1016/j.jsbmb.2008.06.015. View

19.

Chappard D, Legrand E, Basle M, Fromont P, Racineux J, Rebel A . Altered trabecular architecture induced by corticosteroids: a bone histomorphometric study. J Bone Miner Res. 1996; 11(5):676-85. DOI: 10.1002/jbmr.5650110516. View

20.

Lane N, Yao W, Balooch M, Nalla R, Balooch G, Habelitz S . Glucocorticoid-treated mice have localized changes in trabecular bone material properties and osteocyte lacunar size that are not observed in placebo-treated or estrogen-deficient mice. J Bone Miner Res. 2006; 21(3):466-76. PMC: 1797152. DOI: 10.1359/JBMR.051103. View